US Broker Ratings

Boston Scientific Corporation (BSX) Investor Outlook: Impressive 33.84% Potential Upside Amid Strong Buy Ratings

Boston Scientific Corporation (BSX), a stalwart in the medical devices industry, continues to capture investor interest with its robust market position and promising growth prospects. With a market capitalization of..

STERIS plc (STE) Stock Analysis: Understanding the 12.55% Upside Potential

Investors looking for robust opportunities in the healthcare sector might find STERIS plc (NYSE: STE) an intriguing prospect. With a market capitalization of $22.79 billion, STERIS plc is a prominent..

Merck & Company, Inc. (MRK) Stock Analysis: Is the Current Valuation Justified for Investors?

Merck & Company, Inc. (NYSE: MRK) stands as a formidable entity in the healthcare sector, specifically within the general drug manufacturing industry. With a market capitalization of $366 billion, Merck..

Alcon Inc. (ALC) Stock Analysis: A Closer Look at Its 18.37% Potential Upside

Alcon Inc. (NYSE: ALC), a prominent player in the healthcare sector, particularly within the medical instruments and supplies industry, continues to capture investor attention with its robust market positioning and..

argenx SE (ARGX) Investor Outlook: Analyzing the 14.89% Potential Upside in Biotechnology

In the dynamic world of biotechnology, argenx SE (NASDAQ: ARGX) stands as a formidable player, captivating investor attention with its promising growth prospects and impressive market performance. With a current..

Elevance Health, Inc. (ELV) Stock Analysis: Exploring a 13.86% Potential Upside for Investors

As the healthcare industry continues to evolve, Elevance Health, Inc. (NYSE: ELV) stands out as a significant player in the healthcare plans sector. With a market capitalization of $85.54 billion,..

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Navigating a 25.93% Upside Potential in the Healthcare Sector

IDEXX Laboratories, Inc. (NASDAQ: IDXX) is a prominent player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $43.72 billion, the company has..

Centene Corporation (CNC) Stock Analysis: Navigating a 10.68% Potential Upside in Healthcare

Centene Corporation (NYSE: CNC), a prominent player in the healthcare sector, is capturing the attention of investors with its substantial market presence and growth potential. With a market capitalization of..

The Cigna Group (CI) Stock Analysis: Exploring a 22.42% Potential Upside and Strong Buy Ratings

The Cigna Group (NYSE: CI), an established name in the healthcare plans industry, presents a compelling opportunity for investors seeking exposure to the healthcare sector. With a market capitalization of..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: A Closer Look at Its 28.29% Potential Upside

Intuitive Surgical, Inc. (NASDAQ: ISRG), a leader in the healthcare sector specializing in medical instruments and supplies, currently stands as a significant player with a robust market capitalization of $133.49..

Zoetis Inc. (ZTS)

⚠️ No article content returned.

..

Edwards Lifesciences Corporation (EW): Investor Outlook Highlights 11.92% Potential Upside

Edwards Lifesciences Corporation (NYSE: EW), a stalwart in the medical devices industry, continues to capture investor attention with its innovative cardiovascular solutions and promising growth prospects. With a market capitalization..

Cardinal Health, Inc. (CAH)

⚠️ No article content returned.

..

Alnylam Pharmaceuticals (ALNY) Investor Outlook: Exploring a 56% Potential Upside in Biotech Innovation

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a leader in the biotechnology sector, presents a compelling investment narrative for those keen on healthcare innovation. With a market capitalization of $31.73 billion and..

Sanofi (SNY) Stock Analysis: A Healthcare Giant with 19.86% Upside Potential and a Robust Dividend Yield

Sanofi (SNY), a leading player in the global healthcare sector, presents a compelling opportunity for investors seeking both growth and income. As a French-based pharmaceutical giant with a market capitalization..

GSK plc (GSK) Stock Analysis: 15% Potential Upside Amid Strong Dividend Yield

GSK plc (NYSE: GSK), a stalwart in the healthcare sector, stands as a compelling case for investors seeking stability and growth in the drug manufacturing industry. With a market capitalization..

Thermo Fisher Scientific Inc. (TMO): Investor Outlook with a 1.49% Potential Upside and Strong Buy Ratings

Thermo Fisher Scientific Inc. (NYSE: TMO), a stalwart in the Healthcare sector, has made waves with its robust presence in the Diagnostics & Research industry. With a formidable market cap..

BioNTech SE (BNTX) Stock Analysis: Evaluating a 17.86% Potential Upside Amidst Revenue Challenges

BioNTech SE (NASDAQ: BNTX), a prominent player in the biotechnology sector, has captured investor attention with its innovative strides in immunotherapy and mRNA vaccine development. Headquartered in Mainz, Germany, the..

Cencora, Inc. (COR) Stock Analysis: A Healthcare Powerhouse with 14.68% Potential Upside

Cencora, Inc. (NYSE: COR), a stalwart in the healthcare sector, has captured the attention of investors with its expansive reach in the medical distribution industry. As a company with a..

HCA Healthcare, Inc. (HCA) Stock Analysis: Strong Revenue Growth and Analyst Optimism Signal Promising Upside

HCA Healthcare, Inc. (NYSE: HCA), a titan in the U.S. medical care facilities industry, currently boasts a market capitalization of $90.46 billion. This Nashville, Tennessee-headquartered company has a robust portfolio,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds